This week in optometry: October 30-November 3

News
Article

Catch up on what happened in optometry during the week of October 30-November 3.

Catch up with what Optometry Times®' shared this week:

What are microplastics and why should we care?

Katherine M. Mastrota, MS, OD, FAAO, Dipl ABO

Microplastics—omnipresent, indigestible, inhalable, and nonbiodegradable—can be found in the air we breathe and the foods we consume. There is possible evidence that these assumed microplastics particles can pollute human serum.1

Microplastics and nanoplastics are key indicators of the plasticine era, widely spread across different ecosystems. Microplastics and nanoplastics become global stressors because of their inherent physicochemical characteristics and potential impact on natural ecosystems and humans.

Learn more...

The future of telehealth in primary eye care

Thomas A. Wong, OD, FAAO, FNAP

The increased use of technology such as medical imaging, artificial intelligence, and patient communication tools provides opportunities for private practices, universities, community health centers, management centers, and other optometric clinics to collaborate and provide quality care by working with other health care professionals in a changing world. This article will discuss how telehealth can improve access to high-quality vision care and most directly benefit our patients.1

Read on...

Phase 3 OAKS and DERBY studies show clinically meaningful reduction in GA lesion growth

Sydney M Crago, Editor, Modern Retina

Results from the phase 3 OAKS and DERBY studies evaluating pegcetacoplan injection (SYFOVRE) for geographic atrophy (GA) secondary to age-related macular degeneration (AMD) were published in The Lancet. The results note that the 24-month results saw clinically meaningful reduction of GA lesion growth with increasing effects over time in both every-other-month and monthly injections. The results also noted a well-demonstrated safety profile in a broad population of more than 1,200 patients.1

More here...

Charting the path to optimal eye emergency care at CRU 2023

Steven A. Greenstein, MD; Sheryl Stevenson, Eye Care Group Editorial Director; Kassi Jackson, Editor

Set against the backdrop of California’s Napa Valley, the second annual Current, Relevant, Useful (CRU) Eye Symposium will take place at the Silverado Resort and Spa from November 10 to 12, 2023.

Clinicians from the eye care field will delve into various subjects, including anterior segment disease, glaucoma, retina, advanced contact lenses, and myopia management. S. Barry Eiden, OD, FAAO, FSLS; Stephanie Woo, OD, FAAO, FSLS; John D. Gelles, OD, FAAO, FIAOMC, FCLSA, FSLS, FBCLA; and Laura Periman, MD, are the cochairs of the meeting, with honorary ambassador Vance Thompson, MD, FACS.

Steven A. Greenstein, MD, who is part of the faculty for the CRU Eye Symposium, recently spoke with Sheryl Stevenson, Eye Care Group editorial director, to highlight his presentation.

See more...

Recent Videos
Dr Paul Karpecki discusses atropine formulation from Sydnexis following NDA acceptance by FDA
Ali Tafreshi sits down with Optometry Times to discuss Topcon's "Healthcare from the Eye" initiative.
Nora Lee Cothran, OD, FAAO, details a real-world study that found IOP-lowering benefits when switching patients with glaucoma to latanoprostene bunod treatment.
OptiLIFT in action: Dr. Julie McLaughlin's experience with the new device
Mile Brujic, OD, FAAO; Nate Lighthizer, OD, FAAO; Brianna Rhue, OD, FAAO, FSLS; Ben Casella, OD; and Ben Gaddie, OD, FAAO shared their insights from the conference.
The California Optometric Association and the Los Angeles County Optometric Society have compiled resources for optometrists to get involved in continuing relief efforts.
Dr. Stephanie Woo discusses the upcoming CRU Eye Symposium
Agatha Sleboda, OD; Arti Shah, OD, FAAO; and Kent J. Nozacki, OD provide the best tips that they give to their patients during natural disasters events in light of the recent Greater Los Angeles wildfires.
Optometrists local to the Los Angeles area overview their efforts to continue providing support to patients affected by January's wildfires.
© 2025 MJH Life Sciences

All rights reserved.